Kaia Health US team
Kaia Health, a digital therapeutics company, has announced an $8 million funding round; a press release reports that this is the second significant investment this year. The infusion of capital is led by Optum Ventures. According to the press release, Kaia Health has developed a smartphone-based approach for managing a range of chronic conditions—with its leading product focused on musculoskeletal disorders such as chronic back pain.
The investment by Optum Ventures helps Kaia Health address the rising costs of treating MSK-related conditions, the difficulty patients have in accessing gold-standard treatment, and the need for innovative, scaleable and cost-effective technology solutions to confront this issue.
Kaia Health’s 2D motion tracking technology enables users to get real-time feedback on their exercise performance using their smartphone’s camera, which, when taken together with the platform’s psychological and education support, has been proven to outperform conventional therapy.
Konstantin Mehl, founder and CEO of Kaia Health, comments: “The investment from Optum Ventures will allow us to explore integration opportunities throughout the complete patient treatment journey. We are proud to partner with Optum Ventures, a company at the forefront of improving healthcare.”
Optum Ventures’ investment will be used to accelerate sales growth in the US healthcare market, extend the platform into other chronic indications and expand the supporting clinical evidence base.
With three peer-reviewed clinical studies, including a randomized controlled trial recently published in NPJ Digital Medicine, Kaia Health has demonstrated its commitment to creating validated digital therapeutics and has additional clinical studies ongoing in the USA.
